/cloudfront-us-east-1.images.arcpublishing.com/gray/QF5H3LHWMBE2FFQLQY2VMDFLDA.jpg?#)
.jpg?#)
Pharmaceutical giant Sanofi looks to sell consumer health unit, sparks political uproar
France's Economy and Industry ministers, Antoine Armand and Marc Ferracci, are heading to Lisieux this Monday to visit the production sites of popular headache reliever Doliprane. The visit takes place after the maker of the pill, French pharma group Sanofi, said it was in talks to sell off its consumer health business to a US private equity firm. The deal has raised fears for French health sovereignty and job security. We also take a look at the 2024 Paris Motor Show, which kicks off Monday.
France's Economy and Industry ministers, Antoine Armand and Marc Ferracci, are heading to Lisieux this Monday to visit the production sites of popular headache reliever Doliprane. The visit takes place after the maker of the pill, French pharma group Sanofi, said it was in talks to sell off its consumer health business to a US private equity firm. The deal has raised fears for French health sovereignty and job security. We also take a look at the 2024 Paris Motor Show, which kicks off Monday.
